1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Avid Bioservices, Inc.

Avid Bioservices, Inc.

CDMO
Avid Bioservices, Inc.US flagNASDAQ Capital Market
12.49
USD
- -
- -
798.90MMarket Cap

Total Valuation

Avid Bioservices, Inc. carries a market capitalization of 798.90M, placing it among publicly traded companies globally. Its enterprise value stands at 805.56M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap798.90M
Enterprise Value805.56M

Share Statistics

Avid Bioservices, Inc. currently has 63.96M shares outstanding.

Shares Outstanding63.96M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 4.21, and the price-to-book ratio stands at -1.07.

PE RatioN/A
PS Ratio4.21
PB Ratio-1.07
P/TBV Ratio14.14
P/FCF Ratio31.36
P/OCF Ratio120.47

Enterprise Valuation

EV / Sales5.35
EV / EBITDAN/A
EV / EBITN/A
EV / FCF14.25

Financial Position

Avid Bioservices, Inc. maintains a current ratio of 1.30, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 458.68, indicating elevated leverage, while an interest coverage ratio of -0.94 demonstrates limited ability to service its debt obligations.

Current Ratio1.30
Quick Ratio0.86
Debt / Equity458.68
Debt / EBITDA-25.99
Interest Coverage-0.94

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-39.08
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.17

Taxes

Income Tax116.82M
Effective Tax RateN/A

Stock Price Statistics

Avid Bioservices, Inc.'s stock has gained approximately 42.09329% over the past 52 weeks. The 50-day moving average sits at 12.36, while the 200-day moving average is 10.25.

Beta (5Y)N/A
52-Week Price Change42.09329%
50-Day Moving Average12.36
200-Day Moving Average10.25
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Avid Bioservices, Inc. generated 150.45M in revenue and converted that into -152.05M in net income, yielding earnings per share of -2.39. EBITDA reached -7.91M, while operating income came in at -20.38M.

Revenue150.45M
Gross Profit11.55M
Operating Income-20.38M
Pretax Income-35.23M
Net Income-152.05M
EBITDA-7.91M
EBIT-20.38M
Earnings Per Share (EPS)-2.39

Balance Sheet

Avid Bioservices, Inc. holds 33.42M in cash and equivalents against 205.53M in total debt, resulting in a net debt position of 120.73M. Total book value stands at -594.75M, with working capital of 22.35M providing operational flexibility.

Cash & Cash Equivalents33.42M
Total Debt205.53M
Net Debt120.73M
Equity (Book Value)-594.75M
Book Value Per Share-9.35
Working Capital22.35M

Cash Flow

Avid Bioservices, Inc. produced 5.26M in operating cash flow over the past twelve months. After subtracting -14.94M in capital expenditures, free cash flow totaled -9.68M - equivalent to -0.15 per share.

Operating Cash Flow5.26M
Capital Expenditures-14.94M
Free Cash Flow-9.68M
FCF Per Share-0.15

Margins

Avid Bioservices, Inc. operates with a gross margin of 7.68, reflecting its pricing power and cost economics. The operating margin of -13.55 and net profit margin of -101.07 provide insight into operational efficiency.

Gross Margin7.68
Operating Margin-13.55
Pretax Margin-23.42
Profit Margin-101.07
EBITDA Margin-5.26

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-1.84
FCF Yield3.19

Stock Splits

Avid Bioservices, Inc.'s most recent stock split took place on July 10, 2017 with a 7:1 split ratio.

Last Split Date7/10/2017
Split Ratio7:1

Scores

Avid Bioservices, Inc. posts an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.87